Related Experiment Videos
NGF receptor (p75)-immunoreactivity in the developing primate basal ganglia
1Department of Neurological Sciences, Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois 60612.
The Journal of Comparative Neurology
|January 15, 1993
Summary
The p75 nerve growth factor receptor (NGFr) is present in the developing human basal ganglia, particularly in the globus pallidus and subthalamic nucleus during gestation. Its limited presence in the caudate and putamen suggests a restricted role in neostriatal development.
Area of Science:
- Neuroscience
- Developmental Biology
- Neuroanatomy
Background:
- The p75 nerve growth factor receptor (NGFr) plays a role in neuronal development and survival.
- Understanding the distribution of NGFr in the developing basal ganglia is crucial for elucidating its function in primate brain development.
Purpose of the Study:
- To map the distribution of NGFr in the developing human basal ganglia from mid-gestation through adulthood.
- To investigate the potential role of NGFr in the development of specific basal ganglia nuclei and pathways.
Main Methods:
- Immunohistochemical analysis of human fetal and adult basal ganglia specimens.
- Examination of NGFr expression in the caudate nucleus, putamen, globus pallidus, and subthalamic nucleus across different developmental stages.
Main Results:
- NGFr-immunoreactive neurons were found in the putamen (weeks 16-26) and globus pallidus (weeks 16-26), with fewer in the globus pallidus at week 40.
- Dense NGFr-immunoreactive terminal-like staining was observed in the subthalamic nucleus during mid-gestation (weeks 21-26), absent in adulthood.
- NGFr-immunoreactive fibers were present in the putamen, originating from the basal forebrain.
Conclusions:
- NGF receptor-mediated mechanisms are implicated in primate basal ganglia development.
- NGF receptors appear to have a limited role in primate neostriatal development, possibly acting before week 16.
- An NGFr/trophic interaction is suggested to be essential for the development of the pallidal-subthalamic nucleus pathway.